The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sickle Cell Treatment Market Research Report 2024

Global Sickle Cell Treatment Market Research Report 2024

Publishing Date : Feb, 2022

License Type :
 

Report Code : 1676621

No of Pages : 92

Ask Your Query
Synopsis
Market Analysis and Insights: Global Sickle Cell Treatment Market

The global Sickle Cell Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Blood Transfusion accounting for % of the Sickle Cell Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Sickle Cell Treatment market size is valued at US$ million in 2021, while the North America and Europe Sickle Cell Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Sickle Cell Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sickle Cell Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sickle Cell Treatment market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sickle Cell Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sickle Cell Treatment market.

Global Sickle Cell Treatment Scope and Market Size

Sickle Cell Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sickle Cell Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Blood Transfusion

Bone Marrow Transplant

Pharmacotherapy

Segment by Application

Hospitals

Clinics

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Novartis AG

Global Blood Therapeutics Inc.

EMI Holding, Inc.

Addmedica Inc.

Medunik USA.Inc.

Bristol Myers Squibb Co.

Baxter Inc.

Bluebird Biotechnology

Pfizer Inc.

Eli-Lilly and Co.

Glycomimetics Inc.

F.Hoffmann-La Roche

CRISPR Therapeutics
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sickle Cell Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Blood Transfusion

1.2.3 Bone Marrow Transplant

1.2.4 Pharmacotherapy

1.3 Market by Application

1.3.1 Global Sickle Cell Treatment Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Sickle Cell Treatment Market Perspective (2017-2028)

2.2 Sickle Cell Treatment Growth Trends by Region

2.2.1 Sickle Cell Treatment Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Sickle Cell Treatment Historic Market Size by Region (2017-2022)

2.2.3 Sickle Cell Treatment Forecasted Market Size by Region (2023-2028)

2.3 Sickle Cell Treatment Market Dynamics

2.3.1 Sickle Cell Treatment Industry Trends

2.3.2 Sickle Cell Treatment Market Drivers

2.3.3 Sickle Cell Treatment Market Challenges

2.3.4 Sickle Cell Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sickle Cell Treatment Players by Revenue

3.1.1 Global Top Sickle Cell Treatment Players by Revenue (2017-2022)

3.1.2 Global Sickle Cell Treatment Revenue Market Share by Players (2017-2022)

3.2 Global Sickle Cell Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sickle Cell Treatment Revenue

3.4 Global Sickle Cell Treatment Market Concentration Ratio

3.4.1 Global Sickle Cell Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Treatment Revenue in 2021

3.5 Sickle Cell Treatment Key Players Head office and Area Served

3.6 Key Players Sickle Cell Treatment Product Solution and Service

3.7 Date of Enter into Sickle Cell Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Sickle Cell Treatment Breakdown Data by Type

4.1 Global Sickle Cell Treatment Historic Market Size by Type (2017-2022)

4.2 Global Sickle Cell Treatment Forecasted Market Size by Type (2023-2028)

5 Sickle Cell Treatment Breakdown Data by Application

5.1 Global Sickle Cell Treatment Historic Market Size by Application (2017-2022)

5.2 Global Sickle Cell Treatment Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Sickle Cell Treatment Market Size (2017-2028)

6.2 North America Sickle Cell Treatment Market Size by Country (2017-2022)

6.3 North America Sickle Cell Treatment Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Sickle Cell Treatment Market Size (2017-2028)

7.2 Europe Sickle Cell Treatment Market Size by Country (2017-2022)

7.3 Europe Sickle Cell Treatment Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sickle Cell Treatment Market Size (2017-2028)

8.2 Asia-Pacific Sickle Cell Treatment Market Size by Country (2017-2022)

8.3 Asia-Pacific Sickle Cell Treatment Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Sickle Cell Treatment Market Size (2017-2028)

9.2 Latin America Sickle Cell Treatment Market Size by Country (2017-2022)

9.3 Latin America Sickle Cell Treatment Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sickle Cell Treatment Market Size (2017-2028)

10.2 Middle East & Africa Sickle Cell Treatment Market Size by Country (2017-2022)

10.3 Middle East & Africa Sickle Cell Treatment Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Detail

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG Sickle Cell Treatment Introduction

11.1.4 Novartis AG Revenue in Sickle Cell Treatment Business (2017-2022)

11.1.5 Novartis AG Recent Development

11.2 Global Blood Therapeutics Inc.

11.2.1 Global Blood Therapeutics Inc. Company Detail

11.2.2 Global Blood Therapeutics Inc. Business Overview

11.2.3 Global Blood Therapeutics Inc. Sickle Cell Treatment Introduction

11.2.4 Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.2.5 Global Blood Therapeutics Inc. Recent Development

11.3 EMI Holding, Inc.

11.3.1 EMI Holding, Inc. Company Detail

11.3.2 EMI Holding, Inc. Business Overview

11.3.3 EMI Holding, Inc. Sickle Cell Treatment Introduction

11.3.4 EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.3.5 EMI Holding, Inc. Recent Development

11.4 Addmedica Inc.

11.4.1 Addmedica Inc. Company Detail

11.4.2 Addmedica Inc. Business Overview

11.4.3 Addmedica Inc. Sickle Cell Treatment Introduction

11.4.4 Addmedica Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.4.5 Addmedica Inc. Recent Development

11.5 Medunik USA.Inc.

11.5.1 Medunik USA.Inc. Company Detail

11.5.2 Medunik USA.Inc. Business Overview

11.5.3 Medunik USA.Inc. Sickle Cell Treatment Introduction

11.5.4 Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.5.5 Medunik USA.Inc. Recent Development

11.6 Bristol Myers Squibb Co.

11.6.1 Bristol Myers Squibb Co. Company Detail

11.6.2 Bristol Myers Squibb Co. Business Overview

11.6.3 Bristol Myers Squibb Co. Sickle Cell Treatment Introduction

11.6.4 Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2017-2022)

11.6.5 Bristol Myers Squibb Co. Recent Development

11.7 Baxter Inc.

11.7.1 Baxter Inc. Company Detail

11.7.2 Baxter Inc. Business Overview

11.7.3 Baxter Inc. Sickle Cell Treatment Introduction

11.7.4 Baxter Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.7.5 Baxter Inc. Recent Development

11.8 Bluebird Biotechnology

11.8.1 Bluebird Biotechnology Company Detail

11.8.2 Bluebird Biotechnology Business Overview

11.8.3 Bluebird Biotechnology Sickle Cell Treatment Introduction

11.8.4 Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2017-2022)

11.8.5 Bluebird Biotechnology Recent Development

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Detail

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. Sickle Cell Treatment Introduction

11.9.4 Pfizer Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.9.5 Pfizer Inc. Recent Development

11.10 Eli-Lilly and Co.

11.10.1 Eli-Lilly and Co. Company Detail

11.10.2 Eli-Lilly and Co. Business Overview

11.10.3 Eli-Lilly and Co. Sickle Cell Treatment Introduction

11.10.4 Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2017-2022)

11.10.5 Eli-Lilly and Co. Recent Development

11.11 Glycomimetics Inc.

11.11.1 Glycomimetics Inc. Company Detail

11.11.2 Glycomimetics Inc. Business Overview

11.11.3 Glycomimetics Inc. Sickle Cell Treatment Introduction

11.11.4 Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2017-2022)

11.11.5 Glycomimetics Inc. Recent Development

11.12 F.Hoffmann-La Roche

11.12.1 F.Hoffmann-La Roche Company Detail

11.12.2 F.Hoffmann-La Roche Business Overview

11.12.3 F.Hoffmann-La Roche Sickle Cell Treatment Introduction

11.12.4 F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2017-2022)

11.12.5 F.Hoffmann-La Roche Recent Development

11.13 CRISPR Therapeutics

11.13.1 CRISPR Therapeutics Company Detail

11.13.2 CRISPR Therapeutics Business Overview

11.13.3 CRISPR Therapeutics Sickle Cell Treatment Introduction

11.13.4 CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2017-2022)

11.13.5 CRISPR Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Sickle Cell Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

Table 2. Key Players of Blood Transfusion

Table 3. Key Players of Bone Marrow Transplant

Table 4. Key Players of Pharmacotherapy

Table 5. Global Sickle Cell Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Sickle Cell Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Sickle Cell Treatment Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Sickle Cell Treatment Market Share by Region (2017-2022)

Table 9. Global Sickle Cell Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Sickle Cell Treatment Market Share by Region (2023-2028)

Table 11. Sickle Cell Treatment Market Trends

Table 12. Sickle Cell Treatment Market Drivers

Table 13. Sickle Cell Treatment Market Challenges

Table 14. Sickle Cell Treatment Market Restraints

Table 15. Global Sickle Cell Treatment Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Sickle Cell Treatment Market Share by Players (2017-2022)

Table 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2021)

Table 18. Ranking of Global Top Sickle Cell Treatment Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Sickle Cell Treatment Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Sickle Cell Treatment Product Solution and Service

Table 22. Date of Enter into Sickle Cell Treatment Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Sickle Cell Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Sickle Cell Treatment Revenue Market Share by Type (2017-2022)

Table 26. Global Sickle Cell Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Sickle Cell Treatment Revenue Market Share by Type (2023-2028)

Table 28. Global Sickle Cell Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Sickle Cell Treatment Revenue Market Share by Application (2017-2022)

Table 30. Global Sickle Cell Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Sickle Cell Treatment Revenue Market Share by Application (2023-2028)

Table 32. North America Sickle Cell Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 33. North America Sickle Cell Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 34. Europe Sickle Cell Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 35. Europe Sickle Cell Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 36. Asia-Pacific Sickle Cell Treatment Market Size by Region (2017-2022) & (US$ Million)

Table 37. Asia-Pacific Sickle Cell Treatment Market Size by Region (2023-2028) & (US$ Million)

Table 38. Latin America Sickle Cell Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 39. Latin America Sickle Cell Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 40. Middle East & Africa Sickle Cell Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 41. Middle East & Africa Sickle Cell Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 42. Novartis AG Company Detail

Table 43. Novartis AG Business Overview

Table 44. Novartis AG Sickle Cell Treatment Product

Table 45. Novartis AG Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 46. Novartis AG Recent Development

Table 47. Global Blood Therapeutics Inc. Company Detail

Table 48. Global Blood Therapeutics Inc. Business Overview

Table 49. Global Blood Therapeutics Inc. Sickle Cell Treatment Product

Table 50. Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 51. Global Blood Therapeutics Inc. Recent Development

Table 52. EMI Holding, Inc. Company Detail

Table 53. EMI Holding, Inc. Business Overview

Table 54. EMI Holding, Inc. Sickle Cell Treatment Product

Table 55. EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 56. EMI Holding, Inc. Recent Development

Table 57. Addmedica Inc. Company Detail

Table 58. Addmedica Inc. Business Overview

Table 59. Addmedica Inc. Sickle Cell Treatment Product

Table 60. Addmedica Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 61. Addmedica Inc. Recent Development

Table 62. Medunik USA.Inc. Company Detail

Table 63. Medunik USA.Inc. Business Overview

Table 64. Medunik USA.Inc. Sickle Cell Treatment Product

Table 65. Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 66. Medunik USA.Inc. Recent Development

Table 67. Bristol Myers Squibb Co. Company Detail

Table 68. Bristol Myers Squibb Co. Business Overview

Table 69. Bristol Myers Squibb Co. Sickle Cell Treatment Product

Table 70. Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 71. Bristol Myers Squibb Co. Recent Development

Table 72. Baxter Inc. Company Detail

Table 73. Baxter Inc. Business Overview

Table 74. Baxter Inc. Sickle Cell Treatment Product

Table 75. Baxter Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 76. Baxter Inc. Recent Development

Table 77. Bluebird Biotechnology Company Detail

Table 78. Bluebird Biotechnology Business Overview

Table 79. Bluebird Biotechnology Sickle Cell Treatment Product

Table 80. Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 81. Bluebird Biotechnology Recent Development

Table 82. Pfizer Inc. Company Detail

Table 83. Pfizer Inc. Business Overview

Table 84. Pfizer Inc. Sickle Cell Treatment Product

Table 85. Pfizer Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 86. Pfizer Inc. Recent Development

Table 87. Eli-Lilly and Co. Company Detail

Table 88. Eli-Lilly and Co. Business Overview

Table 89. Eli-Lilly and Co. Sickle Cell Treatment Product

Table 90. Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 91. Eli-Lilly and Co. Recent Development

Table 92. Glycomimetics Inc. Company Detail

Table 93. Glycomimetics Inc. Business Overview

Table 94. Glycomimetics Inc. Sickle Cell TreatmentProduct

Table 95. Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 96. Glycomimetics Inc. Recent Development

Table 97. F.Hoffmann-La Roche Company Detail

Table 98. F.Hoffmann-La Roche Business Overview

Table 99. F.Hoffmann-La Roche Sickle Cell TreatmentProduct

Table 100. F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 101. F.Hoffmann-La Roche Recent Development

Table 102. CRISPR Therapeutics Company Detail

Table 103. CRISPR Therapeutics Business Overview

Table 104. CRISPR Therapeutics Sickle Cell TreatmentProduct

Table 105. CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2017-2022) & (US$ Million)

Table 106. CRISPR Therapeutics Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Sickle Cell Treatment Market Share by Type: 2021 VS 2028

Figure 2. Blood Transfusion Features

Figure 3. Bone Marrow Transplant Features

Figure 4. Pharmacotherapy Features

Figure 5. Global Sickle Cell Treatment Market Share by Application in 2021 & 2028

Figure 6. Hospitals Case Studies

Figure 7. Clinics Case Studies

Figure 8. Others Case Studies

Figure 9. Sickle Cell Treatment Report Years Considered

Figure 10. Global Sickle Cell Treatment Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Sickle Cell Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Sickle Cell Treatment Market Share by Region: 2021 VS 2028

Figure 13. Global Sickle Cell Treatment Market Share by Players in 2021

Figure 14. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Sickle Cell Treatment Revenue in 2021

Figure 16. North America Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 17. North America Sickle Cell Treatment Market Share by Country (2017-2028)

Figure 18. United States Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 19. Canada Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Europe Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Sickle Cell Treatment Market Share by Country (2017-2028)

Figure 22. Germany Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. France Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. U.K. Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Italy Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. Russia Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. Nordic Countries Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Asia-Pacific Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Asia-Pacific Sickle Cell Treatment Market Share by Region (2017-2028)

Figure 30. China Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Japan Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. South Korea Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Southeast Asia Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. India Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Australia Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Latin America Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Latin America Sickle Cell Treatment Market Share by Country (2017-2028)

Figure 38. Mexico Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Brazil Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Middle East & Africa Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Middle East & Africa Sickle Cell Treatment Market Share by Country (2017-2028)

Figure 42. Turkey Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Saudi Arabia Sickle Cell Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. Novartis AG Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 45. Global Blood Therapeutics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 46. EMI Holding, Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 47. Addmedica Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 48. Medunik USA.Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 49. Bristol Myers Squibb Co. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 50. Baxter Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 51. Bluebird Biotechnology Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 52. Pfizer Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 53. Eli-Lilly and Co. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 54. Glycomimetics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 55. F.Hoffmann-La Roche Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 56. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Treatment Business (2017-2022)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock